Artículos del autor

solaci

Coronary disease

Successful CTO reduces local and remote residual ischemia

Courtesy of Dr. Carlos Fava. The presence of Chronic Total Occlusion (CTO) is about 30%, with an ischemic threshold between...
solaci -
Antiplatelet

Post DES Dual Antiplatelet Therapy Still under Debate

The NIPPON trial (Nobori Dual Antiplatelet Therapy as Appropriate Duration) was a randomized study comparing a short dual...
solaci -
Acute coronary syndromes

PCI Mortality and Volume in One Center: Associated?

The relationship between procedure volume and prognosis after a percutaneous coronary intervention remains unclear. Intuitively, we tend...
solaci -
Chronic Ischemic cardiopathy

Glycemic control and risk of repeat revascularization

The association between glycemic control after coronary angioplasty and outcomes of the latter is controversial in many...
solaci -
Institutional News

Date of CRT 2018 Already Confirmed

The annual event reuniting more than 2500 endovascular specialists and interventionists will be held on March 3...
solaci -
Mitral valve

MitraClip: Should We Intervene Earlier?

Courtesy of Dr. Carlos Fava. Repairing the mitral valve with Mitraclip has become an alternative for high risk or inoperable symptomatic patients,...
solaci -
Institutional News

Reciprocity agreement between ESVB and SOLACI

On behalf of all who make part of SOLACI, we are thrilled to announce a reciprocity and...
solaci -
Structural heart disease

Post-dilation in TAVI associated to more stroke and more paravalvular regurgitation

Courtesy of Dr. Carlos Fava. Moderate/severe paravalvular regurgitation (PVR) after TAVR is present in 10%-14% of all cases, according to different...
solaci -